iRhythm

By Dave Muoio November 15, 2017
Connected wearable patch makers will ship 35.1 million units annually by 2022, with 80 percent of these being used in clinical applications, according to a recent report from market intelligence firm Tractica. The report also forecasts a total $7.9 billion in revenue for the patch market by the same year, all of which suggests a substantial escalation from the 966,000 units the analysts wrote...
By Jonah Comstock August 8, 2017
iRhythm Technologies, maker of the ZIO patch peel-and-stick heart monitor, announced on its second quarter earnings call that it increased its revenue 52 percent year over year (for a total revenue of $23.9 million) and achieved its first cash flow break-even quarter. CEO Kevin King also shared a rough timetable for the company's forthcoming Zio AT product, which received FDA clearance in June....
By Jonah Comstock July 11, 2017
A team of researchers from Stanford University, working with cardiac monitoring company iRhythm, have created an AI algorithm that, in a small proof-of-concept trial, outperformed board-certified cardiologists at identifying various types of arrhythmias from ECGs. The results have been published to arXiv, an online archive for scientific papers, but have not yet appeared in a peer-reviewed...
By Jonah Comstock June 8, 2017
iRhythm Zio is in many ways a poster child for a connected health company. The company, which makes a peel-and-stick patch for mobile ECG recording, is one of the few wearable medical device companies to go public, and few digital technologies have as soundly improved on the status quo as Zio has on the Holter monitor, a long-term legacy monitoring technology. There's only one problem with...
By Jonah Comstock April 10, 2017
Chinese medical supply company Shenzen-Kingyield has received FDA 510(k) clearance for a Bluetooth-connected blood pressure monitor. The device is worn on the wrist and sends data to a smartphone for archiving or analysis, according to the clearance document, and the device has been cleared for over the counter sales. The company makes a variety of blood pressure monitors, blood glucose monitors...
By Jonah Comstock October 20, 2016
iRhythm, the wearable heart monitor company that announced its intention to IPO last month, went public today and increased its share price and number of shares on offer, raising the value of its IPO from an expected $86 million to $107 million. The company is offering 6,294,118 shares of its common stock at a public offering price of $17.00 per share, before underwriting discounts. Underwriters...
By Jonah Comstock September 26, 2016
iRhythm, maker of the wearable-and-wireless-but-not-connected Zio heart rate monitoring system, has filed with the SEC to raise up to $86 million in an initial public offering.  The Zio patch, iRhythm's sole product as of now, is a small wearable sensor, used for multi-day monitoring of arrhythmias in cardiac patients (up to a fortnight). Unlike many participants in that space, however, the...
By Jonah Comstock November 30, 2015
The Scripps Translational Science Institute is working with Aetna and Johnson & Johnson to launch a trial that will test iRhythm's Zio Patch and the Amiigo activity tracker as possible new ways to screen at-risk populations for atrial fibrillation. "What we really want at the end of this study is to be able to best understand what the right way is to screen high-risk patients for atrial...
By Jonah Comstock May 18, 2015
Research firm Tractica predicts that worldwide unit shipments of clinical and non-clinical connected wearable patches will grow to 12.3 million per year by 2020. Last year, annual shipments were just 67,000. The market for such connected patches, Tractica predicts, will hit $3.3 billion per year. Tractica describes the category as including "patches, tattoos, or small devices that are affixed to...
By Jonah Comstock May 22, 2014
iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture Partners also participated in the round. This brings the company's total disclosed funding to about $85 million, based on SEC filings and company announcements. As part of the latest investment deal...